Molbio Diagnostics Ltd vs Shalby Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Molbio Diagnostics Ltd is ₹ 1237 as of 23 Oct 15:30 . The P/E Ratio of Molbio Diagnostics Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Shalby Ltd changed from 25.7 on March 2021 to 36.5 on March 2026 . This represents a CAGR of 6.02% over 6 years The Market Cap of Molbio Diagnostics Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Shalby Ltd changed from ₹ 1089 crore on March 2021 to ₹ 1370 crore on March 2026 . This represents a CAGR of 3.90% over 6 years The revenue of Molbio Diagnostics Ltd for the Jun '26 is ₹ 411.48 crore as compare to the Mar '26 revenue of ₹ 565.41 crore. This represent the decline of -27.22% The revenue of Shalby Ltd for the Jun '26 is ₹ 338.64 crore as compare to the Mar '26 revenue of ₹ 295.52 crore. This represent the growth of 14.59% The ebitda of Molbio Diagnostics Ltd for the Jun '26 is ₹ 103.68 crore as compare to the Mar '26 ebitda of ₹ 163.51 crore. This represent the decline of -36.59% The ebitda of Shalby Ltd for the Jun '26 is ₹ 49 crore as compare to the Mar '26 ebitda of ₹ 37.43 crore. This represent the growth of 30.91% The net profit of Molbio Diagnostics Ltd changed from ₹ -23.94 crore to ₹ 52.74 crore over 5 quarters. This represents a CAGR of NaN% The net profit of Shalby Ltd changed from ₹ 14.74 crore to ₹ 10.5 crore over 9 quarters. This represents a CAGR of -13.99% The Dividend Payout of Molbio Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Shalby Ltd changed from 25.19 % on March 2021 to 0 % on March 2026 . This represents a CAGR of -100.00% over 6 years .

About Molbio Diagnostics Ltd

Molbio Diagnostics Limited was originally incorporated as Molbio Diagnostics Private Limited' at Panaji, as a private company dated October 20, 2000.
Thereafter, Company was converted from a private limited company to a public limited company, and the name of Company was changed to Molbio Diagnostics Limited, and a fresh certificate of incorporation dated January 16, 2025 was issued to Company by the RoC. Company is innovative point-of-care (POC) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases.
The Company entered into a joint venture agreement in August, 2011 with Bigtec Innovations Private Limited and Bigtec Private Limited, which started operations in 2000.
Bigtec Innovations Private Limited got merged with the Company in 2015.

About Shalby Ltd

Shalby Limited was originally incorporated as a Private Limited Company with the name 'Shalby Hospital Private Limited' on August 30, 2004.
Subsequently, the Company was converted to a Public Limited Company and the name was changed to 'Shalby Hospital Public Limited' on May 15, 2006.
Further, the name of the Company was changed to Shalby Hospitals Limited on July 26, 2006 and then, again changed to Shalby Limited on February 13, 2008. Shalby Limited is an Ahmedabad-headquartered and one of the leading multi-specialty chain of hospitals in India and provides high-quality and economical healthcare services.
With 15 hospitals and over 2,300 beds across 12 cities, Shalby is now the largest corporate hospital group in Western and Central India.
The Hospitals are tertiary care hospitals, few of which offer quaternary healthcare services to patients in various areas of specialisation such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, and renal transplantations.

FAQs for the comparison of null and Shalby Ltd

Which company has a larger market capitalization, Molbio Diagnostics Ltd or Shalby Ltd?

Market cap of Molbio Diagnostics Ltd is 14,262 Cr while Market cap of Shalby Ltd is 1,227 Cr

What are the key factors driving the stock performance of Molbio Diagnostics Ltd and Shalby Ltd?

The stock performance of Molbio Diagnostics Ltd and Shalby Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Molbio Diagnostics Ltd and Shalby Ltd?

As of October 24, 2026, the Molbio Diagnostics Ltd stock price is INR ₹1237.65. On the other hand, Shalby Ltd stock price is INR ₹113.65.

How do dividend payouts of Molbio Diagnostics Ltd and Shalby Ltd compare?

To compare the dividend payouts of Molbio Diagnostics Ltd and Shalby Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.